Day: April 22, 2024

THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, BY ANY MEANS OR MEDIA, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, NEW ZEALAND, JAPAN OR THE REPUBLIC OF SOUTH AFRICA, OR ANY OTHER JURISDICTION IN WHICH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT ITSELF CONSTITUTE A PROSPECTUS OR OFFERING MEMORANDUM NOR DOES IT CONSTITUTE AN ADMISSION DOCUMENT PREPARED IN ACCORDANCE WITH THE AIM RULES OR FORM PART OF ANY OFFER, RECOMMENDATION, INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF ANY OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES IN THE CAPITAL OF THE COMPANY. ACCORDINGLY, THIS ANNOUNCEMENT HAS NOT BEEN APPROVED BY...

Victoria, Seychelles and Geneva, Switzerland, April 22, 2024 (GLOBE NEWSWIRE) — SeyID Platform Will Enable Key eGovernment Initiatives and Further Digital Transformation WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, operating as a holding company, today announced it has been awarded the project to deliver a new Digital Identity platform, “SeyID”, by the Government of Seychelles. SeyID will be linked with different national initiatives covering eGovernment, eTourism and eHealth. Following the successful launch of the SeyID project, which is built upon WISeKey’s WISeID platform for Digital Identity and online security, significant enhancements have been achieved in the realm of secure access and identity...

Oslo, April 22, 2023 — Ensurge Micropower (OSE: ENSU, and OTCQB: ENMPY) (“Ensurge” or the “Company”), today announced it has completed its first shipment of the world’s first fully functional multi-layer solid-state lithium microbatteries.   The batteries were delivered to one of our key customers and strategic technology partners in the consumer electronics industry. This is the first out of a series of shipments that will take place in the near future to Ensurge’s initial group of key customers and technology partners.  The Ensurge 10-micron microbatteries have the energy density and performance to power space-constrained connected devices including wearables, hearables and IoT sensors.  “We look forward to the next phase of collaboration with key customers and technology partners,” said Lars Eikeland, CEO at Ensurge. “Over the...

Court Grants “Transfer under Judicial Supervision” for CDMO facility, safeguarding Mithra’s activities and expediting the M&A process for its Contract Development and Manufacturing Organization. Approval of Judicial Reorganization Proceedings for Novalon SA, facilitating an amicable agreement with some creditors and restructuring the debt of Mithra’s complex therapeutics business. Mithra Advances Monetization Process with Court Protection Measures, marking significant milestones in the company’s commitment to maximizing value for stakeholders while ensuring operational continuity.LIEGE, Belgium, April 22, 2024 (GLOBE NEWSWIRE) — Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces the Liege Company Court has granted the company two crucial protection measures,...

Ipsen enters into an option agreement to receive exclusive global rights to two candidates pursued under the collaborationFollowing development candidate validation, Ipsen will assume responsibility for further development and commercialization, leveraging existing neuroscience expertise in movement disordersThis promising platform technology created by Skyhawk allows for the exploration of previously undruggable RNA targets with small molecules, expanding the disease target landscape1PARIS, FRANCE; BOSTON, U.S., 22 April 2024 – Ipsen (Euronext: IPN; ADR: IPSEY) and Skyhawk Therapeutics today announced the signing of an exclusive worldwide collaboration to discover and develop novel small molecules that modulate RNA for rare neurological diseases. The agreement includes an option pursuant to which Ipsen would acquire exclusive...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesPyzchiva® approved as one of first ustekinumab biosimilars in Europe EC approval based on robust development program confirming match to reference medicine in terms of safety, efficacy and quality Sandoz remains committed to accelerating access to potentially life-changing treatments and continues strengthening immunology portfolioBasel, April 22, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announces that the European Commission (EC) has granted marketing authorization for Pyzchiva®* (biosimilar ustekinumab), developed and registered by Samsung Bioepis. Pyzchiva® is a key biosimilar value driver for the company over the mid-term and this approval is a major step in advancing Sandoz growth strategy. Pyzchiva® is approved as a biologic...

GUANGZHOU, China, April 22, 2024 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, will attend Beijing Auto Show 2024 and host its Press Conference on Thursday, April 25, 2024, showcasing its latest AI-powered tech advancement and Smart EV innovations. Live Broadcast from China – English Replay Available The live broadcast of the XPENG Beijing Auto Show 2024 Press Conference will begin Thursday, April 25, with an English language replay available on Thursday, April 25, via the following links: Chinese Live Broadcast 10:20AM Thursday April 25 Beijing Time (GMT+8, or 10:20 PM Wednesday April 24 US Eastern Daylight Time) XPENG OFFICIAL WEBSITE CHINESE English Replay 8:00PM Thursday April 25 Beijing Time...